Improvement of perioperative and postoperative management after hepatic resection for HCC by the regulation of hepatic stellate cells.
通过肝星状细胞的调节改善 HCC 肝切除术后的围手术期和术后管理。
基本信息
- 批准号:16390376
- 负责人:
- 金额:$ 8.77万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
1)The involvement of thioredoxin on liver fibrosis and stellate cells activation :Thioredoxin is a small redox-active protein with anti-oxidant and anti-apoptotic effect. We have investigated the protective effect of thioredoxin for hepatic fibrosis. Induction of endogenous thioredoxin was obvious in hepatocytes of thioacetamide-induced fibrotic liver of rats. Overexpression of thioredoxin inhibited tumor necrosis factor-α-induced death of HepG2 cells. Thioacetamide-induced fibrosis and accumulation of malondialdehyde in the liver was suppressed in transgenic mice as compared with wild-type mice. Hepatic stellate cells isolated from transgenic mice was less proliferative than those isolated from wild type mice. Recombinant thioredoxin significantly inhibited DNA synthesis of primary-cultured stellate cells under serum or PDGF-BB stimulation. Thioredoxin failed to control collagen gene expression in cultured stellate cells. Thioredoxin has a potential to control hepatic fibrosis via inh … More ibiting hepatocyte death, proliferation of stellate cells and oxidative stress.2 )Effect of NAC (N-acetylcisteine) on hepatic function and HCC recurrence of patients with chronic hepatitis and on postoperative liver failure after hepatic resection :NAC had been administered to 3 patients with chronic hepatitis for 6 months after hepatic resection for HCC. Markers for tumor recurrence(AFP, PIVKA-II) and liver fibrosis(P-III-P, type IV collagen), figures of AST and ALT, and the number of platelets were investigated. In two patients, figures of tumor markers were improved or unchanged. Markers of fibrosis were improved in 2 patients. Figures of AST, ALT and the number of platelets were improved in 1 patient.In addition, we had administered NAC to 2 post-hepatectomized patients with hyperbilirubinemia. In one patient, serum bilirubin level decreased after enteral administration of NAC. On the other hand, NAC administration did not improve serum bilirubin level of the other patient. In this research, we can not clearly show the evidence of efficacy of NAC on management of hepatic function and HCC recurrence and on postoperative liver failure after hepatic resection. Additional evaluation will be necessary.3)Hepatic microcirculation and Rock/Rho kinase inhibitor, Y-27632Rock/Rho kinase inhibitor, Y-27632 is also known to prevent activation of hepatic stellate cell and prevent fibrosis. We have investigated it in ischemia/reperfusion model of rat liver using hemi-lateral clamp of the liver. Y-27632 protected ischemia/reperfusion-induced injury of the liver through remarkable improvement of hepatic microcirculation, which was observed by intravital microscopy. Diamiter of sinusoid and postsinusoidal venule, sinusoidal perfusion rate were maintained as compared to sham group. Adherence of leucocytes in the sinusoid and postsinusoidal venule was much less, which results also in protection of disturbance of the blood flow. Y-27632 also exhibited to improve disturbance of microcirculation due to endotoxemia. Less
1)硫氧还蛋白参与肝纤维化和星状细胞活化:硫氧还蛋白是一种小的氧化还原活性蛋白,具有抗氧化和抗凋亡作用。我们研究了硫氧还蛋白对肝纤维化的保护作用。硫代乙酰胺诱导的大鼠肝纤维化的肝细胞内源性硫氧还蛋白的诱导是明显的。硫氧还蛋白的过度表达抑制肿瘤坏死因子-α诱导的 HepG2 细胞死亡。与野生型小鼠相比,转基因小鼠中硫代乙酰胺诱导的纤维化和丙二醛在肝脏中的积累受到抑制。从转基因小鼠中分离的肝星状细胞的增殖能力低于从野生型小鼠中分离的肝星状细胞。重组硫氧还蛋白在血清或PDGF-BB刺激下显着抑制原代培养的星状细胞的DNA合成。硫氧还蛋白无法控制培养的星状细胞中的胶原蛋白基因表达。硫氧还蛋白有潜力通过抑制肝细胞死亡、星状细胞增殖和氧化应激来控制肝纤维化。2)NAC(N-乙酰半胱氨酸)对慢性肝炎患者肝功能和 HCC 复发以及肝切除术后肝功能衰竭的影响:NAC 已对 3 名慢性肝炎患者进行了 6 次治疗 HCC 肝切除术后数月。检测肿瘤复发标志物(AFP、PIVKA-II)、肝纤维化标志物(P-III-P、IV型胶原)、AST、ALT数值以及血小板数量。两名患者的肿瘤标志物数值有所改善或没有变化。 2 名患者的纤维化标志物得到改善。 1 名患者的 AST、ALT 和血小板数量有所改善。此外,我们还对 2 名肝切除后出现高胆红素血症的患者进行了 NAC 治疗。一名患者肠内给予 NAC 后血清胆红素水平下降。另一方面,NAC 给药并没有改善另一名患者的血清胆红素水平。在这项研究中,我们无法清楚地证明 NAC 对肝功能管理、HCC 复发以及肝切除术后肝衰竭的疗效证据。需要进行额外的评估。3) 肝脏微循环和 Rock/Rho 激酶抑制剂 Y-27632 Rock/Rho 激酶抑制剂 Y-27632 也可防止肝星状细胞活化并防止纤维化。我们使用肝脏半侧钳在大鼠肝脏缺血/再灌注模型中对其进行了研究。通过活体显微镜观察到,Y-27632 通过显着改善肝脏微循环来保护缺血/再灌注引起的肝脏损伤。与假手术组相比,血窦和窦后微静脉的直径、血窦灌注率保持不变。血窦和窦后微静脉中白细胞的粘附要少得多,这也导致血流紊乱的保护。 Y-27632 还表现出改善内毒素血症引起的微循环障碍的作用。较少的
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cytoprotective Effects of Geranylgeranylacetone against Retinal Photooxidative Damage
- DOI:10.1523/jneurosci.4866-04.2005
- 发表时间:2005-03
- 期刊:
- 影响因子:0
- 作者:M. Tanito;Yongwon Kwon;N. Kondo;J. Bai;H. Masutani;Hajime Nakamura;J. Fujii;A. Ohira;J. Yodoi
- 通讯作者:M. Tanito;Yongwon Kwon;N. Kondo;J. Bai;H. Masutani;Hajime Nakamura;J. Fujii;A. Ohira;J. Yodoi
Helicobacter felis-induced gastritis was suppressed in mice overexpressing thioredoxin-1
- DOI:10.1038/labinvest.3700305
- 发表时间:2005-09-01
- 期刊:
- 影响因子:5
- 作者:Kawasaki, K;Nishio, A;Chiba, T
- 通讯作者:Chiba, T
Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection - An analysis of 610 patients over 16 years old
- DOI:10.1097/01.sla.0000217921.28563.55
- 发表时间:2006-08-01
- 期刊:
- 影响因子:9
- 作者:Taura, Kojiro;Ikai, Iwao;Shimahara, Yasuyuki
- 通讯作者:Shimahara, Yasuyuki
Complete response by a combination of 5-fluorouracil and interferon-alpha chemotherapy for lung metastasis of hepatocellular carcinoma after hepatic resection with portal and hepatic vein tumor thrombectomy.
5-氟尿嘧啶和干扰素-α联合化疗对门静脉和肝静脉癌栓切除术后肝细胞癌肺转移的完全缓解。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Hosogi H;Ikai I;Hatano E;Taura K;Fujii H;Yamamoto N;Shimahara Y.
- 通讯作者:Shimahara Y.
Thioredoxin, a redox-regulating protein, is expressed in spontaneous myocarditis in inbred strains of mice.
- DOI:10.1016/j.ijcard.2003.10.009
- 发表时间:2004-06
- 期刊:
- 影响因子:3.5
- 作者:M. Miyamoto;C. Kishimoto;Masaomi Nimata;Hajime Nakamura;J. Yodoi
- 通讯作者:M. Miyamoto;C. Kishimoto;Masaomi Nimata;Hajime Nakamura;J. Yodoi
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HATANO Etsuro其他文献
HATANO Etsuro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HATANO Etsuro', 18)}}的其他基金
Establishment of risk assessment for liver resection by liver stiffness measurement with acoustic radio force impulse (ARFI)
声射电脉冲(ARFI)肝脏硬度测量建立肝切除风险评估
- 批准号:
24659605 - 财政年份:2012
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Modification of endoplasmic reticulum stress expands surgical indication in hepatocellular carcinom a
内质网应激的改变扩大了肝细胞癌的手术指征
- 批准号:
20591609 - 财政年份:2008
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution to the extended hepatectomy by the modulation of endoplasmic reticulum stress-induced cell death
通过调节内质网应激诱导的细胞死亡对扩大肝切除术的贡献
- 批准号:
15591401 - 财政年份:2003
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
Thioredoxin-2调控糖尿病肾病炎症的作用及机制
- 批准号:n/a
- 批准年份:2022
- 资助金额:100.0 万元
- 项目类别:省市级项目
Thioredoxin-2募集TRIM31泛素化降解NLRP3在糖尿病肾病炎症反应中的作用和机制
- 批准号:82070752
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
GIT1通过thioredoxin保护继发性脊髓损伤的机制研究
- 批准号:81772351
- 批准年份:2017
- 资助金额:58.0 万元
- 项目类别:面上项目
二甲双胍对不同分子亚型乳腺癌放疗增敏作用的差异及其机制的研究
- 批准号:81502665
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖对线粒体TrxR2/Trx2系统的抑制在糖尿病心肌病中的作用及机制
- 批准号:81100155
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
小分子蛋白Thioredoxin -1在脑缺血再灌注损伤中的保护作用及机制研究
- 批准号:81171090
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
以硫氧还蛋白还原酶为靶点的化学生物学研究
- 批准号:21002047
- 批准年份:2010
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
TRX及其信号调节通路在动脉粥样硬化发生与发展中的作用
- 批准号:30570732
- 批准年份:2005
- 资助金额:26.0 万元
- 项目类别:面上项目
相似海外基金
Signaling basis of senescence-associated secretory phenotype and its implications in epithelial ovarian cancer
衰老相关分泌表型的信号基础及其在上皮性卵巢癌中的意义
- 批准号:
10731600 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Elucidation of regulation mechanism of the NLR inflammasome by the thioredoxin system
阐明硫氧还蛋白系统对NLR炎症小体的调节机制
- 批准号:
23K18211 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Regulation and Function of Thioredoxin Interacting Protein (Txnip) in Nonalcoholic Steatohepatitis (NASH)
硫氧还蛋白相互作用蛋白 (Txnip) 在非酒精性脂肪性肝炎 (NASH) 中的调节和功能
- 批准号:
10736673 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Exploring new functions of plastid-localized thioredoxin-like proteins
探索质体定位的硫氧还蛋白样蛋白的新功能
- 批准号:
23KJ0887 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Selenium Metabolism in the Heart: Impact of High Fructose and Low Selenium
心脏中的硒代谢:高果糖和低硒的影响
- 批准号:
10793881 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Selenoprotein-independent biological roles for selenium in selenium deficiency and excess
硒在硒缺乏和过量时的独立于硒蛋白的生物学作用
- 批准号:
10737250 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Platinum-Gold Compounds as Potential Chemo- and Targeted Agents for Ovarian Cancer
铂金化合物作为卵巢癌的潜在化疗药物和靶向药物
- 批准号:
10627602 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Characterizing the Redoxome of Chlamydia and Its Host Cell
衣原体及其宿主细胞氧化还原体的表征
- 批准号:
10723036 - 财政年份:2023
- 资助金额:
$ 8.77万 - 项目类别:
Structure function investigations of radical transfer and disulfide exchange in a class Ia ribonucleotide reductase
Ia类核糖核苷酸还原酶自由基转移和二硫键交换的结构功能研究
- 批准号:
10542661 - 财政年份:2022
- 资助金额:
$ 8.77万 - 项目类别: